Summary

According to our LPI (LP Information) latest study, the global Artificial Intelligence (AI) in Cancer market size was valued at US$ million in 2023. With growing demand in downstream market, the Artificial Intelligence (AI) in Cancer is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Artificial Intelligence (AI) in Cancer market. Artificial Intelligence (AI) in Cancer are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artificial Intelligence (AI) in Cancer. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artificial Intelligence (AI) in Cancer market.
Integration of AI technology in cancer care could improve the accuracy and speed of diagnosis, aid clinical decision-making, and lead to better health outcomes. AI-guided clinical care has the potential to play an important role in reducing health disparities, particularly in low-resource settings.
Key Features:
The report on Artificial Intelligence (AI) in Cancer market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Artificial Intelligence (AI) in Cancer market. It may include historical data, market segmentation by Type (e.g., Surgery, Radiotherapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artificial Intelligence (AI) in Cancer market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artificial Intelligence (AI) in Cancer market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artificial Intelligence (AI) in Cancer industry. This include advancements in Artificial Intelligence (AI) in Cancer technology, Artificial Intelligence (AI) in Cancer new entrants, Artificial Intelligence (AI) in Cancer new investment, and other innovations that are shaping the future of Artificial Intelligence (AI) in Cancer.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artificial Intelligence (AI) in Cancer market. It includes factors influencing customer ' purchasing decisions, preferences for Artificial Intelligence (AI) in Cancer product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artificial Intelligence (AI) in Cancer market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artificial Intelligence (AI) in Cancer market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artificial Intelligence (AI) in Cancer market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artificial Intelligence (AI) in Cancer industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artificial Intelligence (AI) in Cancer market.
Market Segmentation:
Artificial Intelligence (AI) in Cancer market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Phototherapy
Gene Therapy
Sonodynamic Therapy
Segmentation by application
Diagnosis
Therapy
Prognosis
Health Management
Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IBM
Microsoft
NVIDIA
Intel
GE Healthcare
Johnson & Johnson
Cancer Center.ai
Digital Reasoning
Varian Medical Systems
Niramai
Densitas
MammoScreen
MVision AI
Volpara
LungLifeAI

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Intelligence (AI) in Cancer Market Size 2019-2030
2.1.2 Artificial Intelligence (AI) in Cancer Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Artificial Intelligence (AI) in Cancer Segment by Type
2.2.1 Surgery
2.2.2 Radiotherapy
2.2.3 Chemotherapy
2.2.4 Immunotherapy
2.2.5 Phototherapy
2.2.6 Gene Therapy
2.2.7 Sonodynamic Therapy
2.3 Artificial Intelligence (AI) in Cancer Market Size by Type
2.3.1 Artificial Intelligence (AI) in Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2019-2024)
2.4 Artificial Intelligence (AI) in Cancer Segment by Application
2.4.1 Diagnosis
2.4.2 Therapy
2.4.3 Prognosis
2.4.4 Health Management
2.4.5 Research
2.5 Artificial Intelligence (AI) in Cancer Market Size by Application
2.5.1 Artificial Intelligence (AI) in Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2019-2024)
3 Artificial Intelligence (AI) in Cancer Market Size by Player
3.1 Artificial Intelligence (AI) in Cancer Market Size Market Share by Players
3.1.1 Global Artificial Intelligence (AI) in Cancer Revenue by Players (2019-2024)
3.1.2 Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence (AI) in Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Intelligence (AI) in Cancer by Regions
4.1 Artificial Intelligence (AI) in Cancer Market Size by Regions (2019-2024)
4.2 Americas Artificial Intelligence (AI) in Cancer Market Size Growth (2019-2024)
4.3 APAC Artificial Intelligence (AI) in Cancer Market Size Growth (2019-2024)
4.4 Europe Artificial Intelligence (AI) in Cancer Market Size Growth (2019-2024)
4.5 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size Growth (2019-2024)
5 Americas
5.1 Americas Artificial Intelligence (AI) in Cancer Market Size by Country (2019-2024)
5.2 Americas Artificial Intelligence (AI) in Cancer Market Size by Type (2019-2024)
5.3 Americas Artificial Intelligence (AI) in Cancer Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence (AI) in Cancer Market Size by Region (2019-2024)
6.2 APAC Artificial Intelligence (AI) in Cancer Market Size by Type (2019-2024)
6.3 APAC Artificial Intelligence (AI) in Cancer Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Intelligence (AI) in Cancer by Country (2019-2024)
7.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2019-2024)
7.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Intelligence (AI) in Cancer by Region (2019-2024)
8.2 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Type (2019-2024)
8.3 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Artificial Intelligence (AI) in Cancer Market Forecast
10.1 Global Artificial Intelligence (AI) in Cancer Forecast by Regions (2025-2030)
10.1.1 Global Artificial Intelligence (AI) in Cancer Forecast by Regions (2025-2030)
10.1.2 Americas Artificial Intelligence (AI) in Cancer Forecast
10.1.3 APAC Artificial Intelligence (AI) in Cancer Forecast
10.1.4 Europe Artificial Intelligence (AI) in Cancer Forecast
10.1.5 Middle East & Africa Artificial Intelligence (AI) in Cancer Forecast
10.2 Americas Artificial Intelligence (AI) in Cancer Forecast by Country (2025-2030)
10.2.1 United States Artificial Intelligence (AI) in Cancer Market Forecast
10.2.2 Canada Artificial Intelligence (AI) in Cancer Market Forecast
10.2.3 Mexico Artificial Intelligence (AI) in Cancer Market Forecast
10.2.4 Brazil Artificial Intelligence (AI) in Cancer Market Forecast
10.3 APAC Artificial Intelligence (AI) in Cancer Forecast by Region (2025-2030)
10.3.1 China Artificial Intelligence (AI) in Cancer Market Forecast
10.3.2 Japan Artificial Intelligence (AI) in Cancer Market Forecast
10.3.3 Korea Artificial Intelligence (AI) in Cancer Market Forecast
10.3.4 Southeast Asia Artificial Intelligence (AI) in Cancer Market Forecast
10.3.5 India Artificial Intelligence (AI) in Cancer Market Forecast
10.3.6 Australia Artificial Intelligence (AI) in Cancer Market Forecast
10.4 Europe Artificial Intelligence (AI) in Cancer Forecast by Country (2025-2030)
10.4.1 Germany Artificial Intelligence (AI) in Cancer Market Forecast
10.4.2 France Artificial Intelligence (AI) in Cancer Market Forecast
10.4.3 UK Artificial Intelligence (AI) in Cancer Market Forecast
10.4.4 Italy Artificial Intelligence (AI) in Cancer Market Forecast
10.4.5 Russia Artificial Intelligence (AI) in Cancer Market Forecast
10.5 Middle East & Africa Artificial Intelligence (AI) in Cancer Forecast by Region (2025-2030)
10.5.1 Egypt Artificial Intelligence (AI) in Cancer Market Forecast
10.5.2 South Africa Artificial Intelligence (AI) in Cancer Market Forecast
10.5.3 Israel Artificial Intelligence (AI) in Cancer Market Forecast
10.5.4 Turkey Artificial Intelligence (AI) in Cancer Market Forecast
10.5.5 GCC Countries Artificial Intelligence (AI) in Cancer Market Forecast
10.6 Global Artificial Intelligence (AI) in Cancer Forecast by Type (2025-2030)
10.7 Global Artificial Intelligence (AI) in Cancer Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 IBM
11.1.1 IBM Company Information
11.1.2 IBM Artificial Intelligence (AI) in Cancer Product Offered
11.1.3 IBM Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 IBM Main Business Overview
11.1.5 IBM Latest Developments
11.2 Microsoft
11.2.1 Microsoft Company Information
11.2.2 Microsoft Artificial Intelligence (AI) in Cancer Product Offered
11.2.3 Microsoft Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Microsoft Main Business Overview
11.2.5 Microsoft Latest Developments
11.3 NVIDIA
11.3.1 NVIDIA Company Information
11.3.2 NVIDIA Artificial Intelligence (AI) in Cancer Product Offered
11.3.3 NVIDIA Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 NVIDIA Main Business Overview
11.3.5 NVIDIA Latest Developments
11.4 Intel
11.4.1 Intel Company Information
11.4.2 Intel Artificial Intelligence (AI) in Cancer Product Offered
11.4.3 Intel Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Intel Main Business Overview
11.4.5 Intel Latest Developments
11.5 GE Healthcare
11.5.1 GE Healthcare Company Information
11.5.2 GE Healthcare Artificial Intelligence (AI) in Cancer Product Offered
11.5.3 GE Healthcare Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GE Healthcare Main Business Overview
11.5.5 GE Healthcare Latest Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Artificial Intelligence (AI) in Cancer Product Offered
11.6.3 Johnson & Johnson Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Johnson & Johnson Main Business Overview
11.6.5 Johnson & Johnson Latest Developments
11.7 Cancer Center.ai
11.7.1 Cancer Center.ai Company Information
11.7.2 Cancer Center.ai Artificial Intelligence (AI) in Cancer Product Offered
11.7.3 Cancer Center.ai Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Cancer Center.ai Main Business Overview
11.7.5 Cancer Center.ai Latest Developments
11.8 Digital Reasoning
11.8.1 Digital Reasoning Company Information
11.8.2 Digital Reasoning Artificial Intelligence (AI) in Cancer Product Offered
11.8.3 Digital Reasoning Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Digital Reasoning Main Business Overview
11.8.5 Digital Reasoning Latest Developments
11.9 Varian Medical Systems
11.9.1 Varian Medical Systems Company Information
11.9.2 Varian Medical Systems Artificial Intelligence (AI) in Cancer Product Offered
11.9.3 Varian Medical Systems Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Varian Medical Systems Main Business Overview
11.9.5 Varian Medical Systems Latest Developments
11.10 Niramai
11.10.1 Niramai Company Information
11.10.2 Niramai Artificial Intelligence (AI) in Cancer Product Offered
11.10.3 Niramai Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Niramai Main Business Overview
11.10.5 Niramai Latest Developments
11.11 Densitas
11.11.1 Densitas Company Information
11.11.2 Densitas Artificial Intelligence (AI) in Cancer Product Offered
11.11.3 Densitas Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Densitas Main Business Overview
11.11.5 Densitas Latest Developments
11.12 MammoScreen
11.12.1 MammoScreen Company Information
11.12.2 MammoScreen Artificial Intelligence (AI) in Cancer Product Offered
11.12.3 MammoScreen Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 MammoScreen Main Business Overview
11.12.5 MammoScreen Latest Developments
11.13 MVision AI
11.13.1 MVision AI Company Information
11.13.2 MVision AI Artificial Intelligence (AI) in Cancer Product Offered
11.13.3 MVision AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 MVision AI Main Business Overview
11.13.5 MVision AI Latest Developments
11.14 Volpara
11.14.1 Volpara Company Information
11.14.2 Volpara Artificial Intelligence (AI) in Cancer Product Offered
11.14.3 Volpara Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Volpara Main Business Overview
11.14.5 Volpara Latest Developments
11.15 LungLifeAI
11.15.1 LungLifeAI Company Information
11.15.2 LungLifeAI Artificial Intelligence (AI) in Cancer Product Offered
11.15.3 LungLifeAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 LungLifeAI Main Business Overview
11.15.5 LungLifeAI Latest Developments
12 Research Findings and Conclusion